Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
- PMID: 26050040
- PMCID: PMC4460187
- DOI: 10.1016/j.neuron.2015.04.022
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia
Abstract
We sought to obtain novel insights into schizophrenia pathogenesis by exploiting the association between the disorder and chromosomal copy number (CNV) burden. We combined data from 5,745 cases and 10,675 controls with other published datasets containing genome-wide CNV data. In this much-enlarged sample of 11,355 cases and 16,416 controls, we show for the first time that case CNVs are enriched for genes involved in GABAergic neurotransmission. Consistent with non-genetic reports of GABAergic deficits in schizophrenia, our findings now show disrupted GABAergic signaling is of direct causal relevance, rather than a secondary effect or due to confounding. Additionally, we independently replicate and greatly extend previous findings of CNV enrichment among genes involved in glutamatergic signaling. Given the strong functional links between the major inhibitory GABAergic and excitatory glutamatergic systems, our findings converge on a broad, coherent set of pathogenic processes, providing firm foundations for studies aimed at dissecting disease mechanisms.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.Mol Psychiatry. 2012 Feb;17(2):142-53. doi: 10.1038/mp.2011.154. Epub 2011 Nov 15. Mol Psychiatry. 2012. PMID: 22083728 Free PMC article.
-
Copy number variation in schizophrenia in Sweden.Mol Psychiatry. 2014 Jul;19(7):762-73. doi: 10.1038/mp.2014.40. Epub 2014 Apr 29. Mol Psychiatry. 2014. PMID: 24776740 Free PMC article.
-
Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function.PLoS Genet. 2010 Sep 9;6(9):e1001097. doi: 10.1371/journal.pgen.1001097. PLoS Genet. 2010. PMID: 20838587 Free PMC article.
-
Genetics in schizophrenia: where are we and what next?Dialogues Clin Neurosci. 2010;12(3):289-303. doi: 10.31887/DCNS.2010.12.3/atiwari. Dialogues Clin Neurosci. 2010. PMID: 20954426 Free PMC article. Review.
-
Genomic copy number variations: A breakthrough in our knowledge on schizophrenia etiology?Neuro Endocrinol Lett. 2012;33(2):183-90. Neuro Endocrinol Lett. 2012. PMID: 22592199 Review.
Cited by
-
Allele-specific DNA methylation maps in monozygotic twins discordant for psychiatric disorders reveal that disease-associated switching at the EIPR1 regulatory loci modulates neural function.Mol Psychiatry. 2021 Nov;26(11):6630-6642. doi: 10.1038/s41380-021-01126-w. Epub 2021 May 7. Mol Psychiatry. 2021. PMID: 33963283
-
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme.Sci Rep. 2018 Oct 19;8(1):15470. doi: 10.1038/s41598-018-33924-8. Sci Rep. 2018. PMID: 30341396 Free PMC article.
-
Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia.Nat Commun. 2020 May 11;11(1):2329. doi: 10.1038/s41467-020-16218-4. Nat Commun. 2020. PMID: 32393757 Free PMC article.
-
Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development.Sci Rep. 2017 Aug 22;7(1):9079. doi: 10.1038/s41598-017-06300-1. Sci Rep. 2017. PMID: 28831049 Free PMC article.
-
Early interventions in risk groups for schizophrenia: what are we waiting for?NPJ Schizophr. 2016 Mar 9;2:16003. doi: 10.1038/npjschz.2016.3. eCollection 2016. NPJ Schizophr. 2016. PMID: 27336054 Free PMC article. Review.
References
-
- Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 2007;8:45–56. - PubMed
-
- Battaglia A., Hoyme H.E., Dallapiccola B., Zackai E., Hudgins L., McDonald-McGinn D., Bahi-Buisson N., Romano C., Williams C.A., Brailey L.L. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics. 2008;121:404–410. - PubMed
Publication types
MeSH terms
Grants and funding
- P50 DA019706/DA/NIDA NIH HHS/United States
- R01 EY020483/EY/NEI NIH HHS/United States
- 5R01CA133996/CA/NCI NIH HHS/United States
- HHSN268200782096C/HL/NHLBI NIH HHS/United States
- 1 X01 HG005274-01/HG/NHGRI NIH HHS/United States
- P50 CA093459/CA/NCI NIH HHS/United States
- 5R01ES011740/ES/NIEHS NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- G0801418/MRC_/Medical Research Council/United Kingdom
- R01 CA133996/CA/NCI NIH HHS/United States
- P50 CA097007/CA/NCI NIH HHS/United States
- 3P50CA093459/CA/NCI NIH HHS/United States
- 100202/WT_/Wellcome Trust/United Kingdom
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- P01 CA089392/CA/NCI NIH HHS/United States
- 5P50CA097007/CA/NCI NIH HHS/United States
- R01 ES011740/ES/NIEHS NIH HHS/United States
- G0800509/MRC_/Medical Research Council/United Kingdom
- P50 CA084724/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
